Literature DB >> 20339027

Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa.

Natacha Germain1, Bogdan Galusca, Dominique Grouselle, Delphine Frere, Stephane Billard, Jacques Epelbaum, Bruno Estour.   

Abstract

CONTEXT: Anorexia nervosa (AN) patients present with restrictive food behavior (AN-R). Some of them develop episodes of bulimia (AN-BP) without any clear pathophysiological explanation to date. Their clinical differentiation is important but not easily performed. Orexigenic/anorexigenic peptides measurements could provide some clues for that matter.
OBJECTIVE: The objective of the study was to determine whether the circadian profile of total and acylated ghrelin, obestatin, and peptide YY (PYY) levels is different in AN-R subjects when compared with AN-BP patients. DESIGN AND SETTINGS: This was a cross-sectional study in an endocrinological unit. PATIENTS AND CONTROL
SUBJECTS: Four groups of age-matched young women: 22 AN-R, 10 AN-BP, 16 normal-weight bulimia nervosa (BN), and nine controls. MAIN OUTCOME MEASURES: Twelve-point circadian profiles of plasma total and acylated ghrelin, obestatin, and PYY were measured.
RESULTS: Total and acylated ghrelin and obestatin circadian levels were increased in AN-R when compared with controls but decreased in both AN-BP and BN groups (P < 0.001). PYY was decreased in all groups with eating disorders. Acylated to total ghrelin ratio was decreased in AN-BP and BN (P < 0.001), whereas obestatin to acylated ghrelin and PYY to acylated ghrelin ratios were increased in both groups with bingeing-purging behavior (P < 0.0001).
CONCLUSIONS: Patients with AN-associated bingeing-purging behavior present a very different profile of appetite regulatory peptides when compared with the pure restrictive type. The assessment of ghrelin (and eventually obestatin) could be of particular interest for differential diagnosis. Very low ghrelin levels and increased anorexigenic to orexigenic peptide ratios suggest either a lack of adaptation to a starvation state or a higher facility to cope with undernutrition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339027     DOI: 10.1210/jc.2009-2196

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

Review 1.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

2.  Characterization of the diurnal rhythm of peptide YY and its association with energy balance parameters in normal-weight premenopausal women.

Authors:  Brenna R Hill; Mary Jane De Souza; Nancy I Williams
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-24       Impact factor: 4.310

Review 3.  Endocrine effects of anorexia nervosa.

Authors:  Karen Klahr Miller
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

Review 4.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

5.  Increased plasma asprosin levels in patients with drug-naive anorexia nervosa.

Authors:  Yanran Hu; Yixiang Xu; Yuchen Zheng; Qing Kang; Zhongze Lou; Qiang Liu; Han Chen; Yunxin Ji; Lei Guo; Chen Chen; Liemin Ruan; Jue Chen
Journal:  Eat Weight Disord       Date:  2020-02-05       Impact factor: 4.652

6.  Abnormal relationships between the neural response to high- and low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa.

Authors:  Laura M Holsen; Elizabeth A Lawson; Kara Christensen; Anne Klibanski; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2014-05-06       Impact factor: 3.222

Review 7.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

8.  Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

9.  Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type.

Authors:  Kamryn T Eddy; Elizabeth A Lawson; Christina Meade; Erinne Meenaghan; Sarah E Horton; Madhusmita Misra; Anne Klibanski; Karen K Miller
Journal:  J Clin Psychiatry       Date:  2015-01       Impact factor: 4.384

Review 10.  Ghrelin and eating disorders.

Authors:  Deniz Atalayer; Charlisa Gibson; Alexandra Konopacka; Allan Geliebter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-30       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.